Raiffeisen Bank International AG Buys 2,971 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Raiffeisen Bank International AG increased its stake in Intuitive Surgical by 5% in Q1, owning 61,846 shares now valued at approximately $30.42 million.
• Intuitive Surgical reported $2.44 billion in revenue for the latest quarter, exceeding analyst expectations and demonstrating a 21.4% year-over-year increase in earnings.
• Analysts have mixed ratings on Intuitive Surgical, with an average rating of "Moderate Buy" and an average price target of $595.95, reflecting varying confidence in the stock's performance.

Raiffeisen Bank International AG lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 61,846 shares of the medical equipment provider's stock after purchasing an additional 2,971 shares during the quarter. Raiffeisen Bank International AG's holdings in Intuitive Surgical were worth $30,418,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Bank Pictet & Cie Europe AG lifted its holdings in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after acquiring an additional 883 shares during the period. World Investment Advisors lifted its holdings in shares of Intuitive Surgical by 97.4% during the fourth quarter. World Investment Advisors now owns 916 shares of the medical equipment provider's stock valued at $478,000 after acquiring an additional 452 shares during the period. Arete Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 78.3% in the fourth quarter. Arete Wealth Advisors LLC now owns 1,908 shares of the medical equipment provider's stock valued at $996,000 after buying an additional 838 shares in the last quarter. Finally, Prudential PLC increased its holdings in shares of Intuitive Surgical by 18.3% in the fourth quarter. Prudential PLC now owns 23,801 shares of the medical equipment provider's stock valued at $12,423,000 after purchasing an additional 3,679 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $9.28 during trading on Thursday, reaching $464.78. 614,725 shares of the stock traded hands, compared to its average volume of 2,003,950. The company has a 50-day moving average of $519.86 and a 200-day moving average of $531.12. The stock has a market capitalization of $166.61 billion, a P/E ratio of 64.87, a price-to-earnings-growth ratio of 5.00 and a beta of 1.59. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the prior year, the firm posted $1.78 EPS. The firm's quarterly revenue was up 21.4% on a year-over-year basis. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent research reports. Truist Financial boosted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Citigroup reissued a "buy" rating and set a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Robert W. Baird decreased their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Finally, Evercore ISI upped their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average price target of $595.95.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the transaction, the insider directly owned 18,520 shares in the company, valued at approximately $9,171,844.80. This represents a 13.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,903 shares of company stock valued at $7,932,778 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.